Authors:
VALLE J
CLEMONS M
BRETTI S
DOUGALL M
ANDERSON H
SCARFFE JH
Citation: J. Valle et al., ETOPOSIDE, DOXORUBICIN (ADRIAMYCIN) AND CISPLATIN CHEMOTHERAPY (EAP) FOR ADVANCED GASTRIC CANCER - RESULTS OF A PHASE-II STUDY AND FINAL REVIEW, GI cancer, 2(3), 1998, pp. 207-213
Authors:
CLEMONS M
LEAHY M
VALLE J
JAYSON G
RANSON M
HAYES S
HOWELL A
Citation: M. Clemons et al., REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - STUDIES EXCLUDING TAXANES, European journal of cancer, 33(13), 1997, pp. 2171-2182
Authors:
CLEMONS M
LEAHY M
VALLE J
JAYSON G
RANSON M
HOWELL A
Citation: M. Clemons et al., REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - THE TAXANES, European journal of cancer, 33(13), 1997, pp. 2183-2193
Citation: Ilp. Beales et al., MISOPROSTOL-ASSOCIATED PLATELET-AGGREGATION DYSFUNCTION AND INCREASEDGASTROINTESTINAL BLOOD-LOSS, European journal of gastroenterology & hepatology, 9(1), 1997, pp. 91-92
Authors:
CLEMONS M
VALLE J
HARRIS M
WEAVER A
ELLENBOGEN S
HOWELL A
Citation: M. Clemons et al., CITROBACTER-FREUNDII AND FATAL NEUTROPENIC ENTEROCOLITIS FOLLOWING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, Annals of oncology, 8(4), 1997, pp. 405-405
Authors:
BETTICHER DC
LEE SM
MORRIS C
CLEMONS M
THATCHER N
Citation: Dc. Betticher et al., DACARBAZINE AND INTERFERON-ALPHA 2A IN ADVANCED MALIGNANT-MELANOMA - HIGH RESPONSE RATE AND PROLONGATION OF RESPONSE DURATION OCCUR IN DIFFERENT PATIENT SUBPOPULATIONS, Melanoma research, 5(4), 1995, pp. 277-282